NSite Medical, a cultivate(MD) portfolio company, received FDA 510(k) clearance to market its artificial intelligence (AI)-based scoliosis scanning application.
NSite Medical’s AI-based application represents a leap forward in scoliosis detection and management. The app utilizes advanced algorithms to analyze spinal curvature with high precision, facilitating early diagnosis and more effective treatment strategies for patients with scoliosis.
In the development of this scoliosis scanning application, ProVoyance, another portfolio company of cultivate(MD), played a pivotal role. ProVoyance’s expertise in medical software development was pivotal not only in advancing the application’s market introduction, but also in securing its FDA clearance.
NSite Medical, a cultivate(MD) portfolio company, received FDA 510(k) clearance to market its artificial intelligence (AI)-based scoliosis scanning application.
NSite Medical’s AI-based application represents a leap forward in scoliosis detection and management. The app utilizes advanced algorithms to analyze spinal curvature with high...
NSite Medical, a cultivate(MD) portfolio company, received FDA 510(k) clearance to market its artificial intelligence (AI)-based scoliosis scanning application.
NSite Medical’s AI-based application represents a leap forward in scoliosis detection and management. The app utilizes advanced algorithms to analyze spinal curvature with high precision, facilitating early diagnosis and more effective treatment strategies for patients with scoliosis.
In the development of this scoliosis scanning application, ProVoyance, another portfolio company of cultivate(MD), played a pivotal role. ProVoyance’s expertise in medical software development was pivotal not only in advancing the application’s market introduction, but also in securing its FDA clearance.
Copy to clipboard 
